ELAN vs TECH · rev $4.44B vs P/E 65, rev $1.22B
Elanco Animal Health (ELAN) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Elanco Animal Health (ELAN) is a drug manufacturers - specialty & generic company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ELAN revenue for 2024-12-31 was $4.44B. Net income was $338.0M. Revenue was up 0.5% from 2023-12-31 to 2024-12-31. ELAN currently screens at market cap $11.80B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ELAN currently screens at market cap $11.80B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ELAN and TECH stock pages for the full models.
Not investment advice.